European Union - English - EMA (European Medicines Agency)

ceva santé animale - clostridium perfringens type c, beta1 toxoid / clostridium perfringens, type a, alpha toxoid / clostridium perfringens, type a, beta2 toxoid / escherichia coli, fimbrial adhesin f4ab / escherichia coli, fimbrial adhesin f4ac / escherichia coli, fimbrial adhesin f5 / escherichia coli, fimbrial adhesin f6 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium - pigs - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce:-           clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6-           clinical signs (diarrhoea during the first days of life) associated with clostridium perfringens type a expressing alpha and beta 2 toxins-           clinical signs and mortality associated with haemorrhagic and necrotising enteritis caused by clostridium perfringens type c expressing beta1 toxin

Ireland - English - HPRA (Health Products Regulatory Authority)

intervet ireland limited - clostridium perfringens type a, alfa toxoid; clostridium perfringens type b, beta toxoid; clostridium perfringens type c, beta toxoid; clostridium perfringens type d, epsilon toxoid; clostridium chauvoei, inactivated; clostridium novyi toxoid; clostridium septicum toxoid; clostridium tetani toxoid; clostridium sordellii toxoid; clostridium haemolyticum, toxoid - suspension for injection - . - clostridium

European Union - English - EMA (European Medicines Agency)

laboratorios hipra, s.a. - clostridioides difficile toxoid a, clostridioides difficile toxoid b, clostridium perfringens, type a, alpha toxoid - immunologicals for suidae, inactivated bacterial vaccines for pigs, clostridium - pigs - for the passive immunisation of neonatal piglets by means of the active immunisation of breeding sows and gilts:- to prevent mortality and reduce clinical signs and macroscopic lesions caused by clostridioides difficile toxins a and b.- to reduce clinical signs and macroscopic lesions caused by clostridium perfringens type a, alpha toxin.

Philippines - English - FDA (Food And Drug Administration)

hipra philippines, inc.; distributor: hipra philippines, inc. - inactivated clostridium perfringens b and e , clostridium novyi a , clostridium septicum a , clostridium chauvoei , clostridium tetani vaccine (vet.) - suspension for injection (im/sc) - formulation: each 2 ml (dose) contains: clostridium perfringens (type b, c, and d) b toxoid .................... > 10 iu/ml clostridium perfringens (type b, c, and d) e toxoid............. >3.5 iu/ml clostridium novyi (type b) a toxoid......... > 2.5 iu/ml clostridium septicum a toxoid ............. clostridium chauvoei ............ ........... 100 % protection clostridium tetani toxoid........... > 2.5 iu/ml

Philippines - English - FDA (Food And Drug Administration)

boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - inactivated escherichia coli fimbrial adhesins , clostridium perfringens b-toxoid vaccine (vet.) - emulsion for injection (im) - formulation: each 2 ml (dose) contains: escherichia coli, f6 adhesins (p4 strain) ......... 21 rp f18ab adhesins (p5 strain) ....... 2 1 rp f4ac adhesins (p6 strain) 2 1 rp f18ac adhesins (p9 strain) .......... 2 1 rp f5 + f41 adhesins (p10 strain) .... 21 rp clostridium perfringens, type c, b-toxoid (czv13 strain) ............ 2 10 iu rp - relative potency iu - international unit (b-antitoxin per ml of rabbit serum)

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

zoetis belgium sa-nv - clostridium haemolyticum toxoid >= 16,5 u/ml; tetanus toxoid >= 2,5 u/ml; clostridium septicum toxoid >= 3,6 u/ml; clostridium novyi toxoid >= 1,2 u/ml; clostridium perfringens type c (beta) toxoid >= 12,4 u/ml; clostridium perfringens type d (epsilon) toxoid >= 5,1 u/ml; clostridium perfringens type a toxoid >= 0,9 u/ml; clostridium perfringens type b toxoid >= 12,4 u/ml; clostridium chauvoei (inactivated) ; clostridium sordellii toxoïd >= 0,8 u/ml - suspension for injection - clostridium chauvoei-septicum; clostridium haemolyticum toxoid; clostridium novyi toxoid; clostridium perfringens; clostridium tetani toxoid; clostridium sordellii toxoid - clostridium - cattle; sheep

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - clostridium perfringens type d - killed; clostridium septicum - killed; clostridium chauvoei - killed; clostridium novyi type b - killed; clostridium tetani-killed; thiomersal - parenteral liquid/solution/suspension - clostridium perfringens type d - killed vaccine active 0.0 undefined; clostridium septicum - killed vaccine active 0.0 undefined; clostridium chauvoei - killed vaccine-microbial active 0.0 undefined; clostridium novyi type b - killed vaccine-microbial active 0.0 undefined; clostridium tetani-killed vaccine-microbial active 0.0 undefined; thiomersal mercury other 0.13 g/l - immunotherapy - cattle | sheep | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | ewe | heifer | h - black disease | blackleg | enterotoxaemia (pulpy kidney) | malignant oedema | tetanus | clostridium perfringens type d | tetanus vaccination

New Zealand - English - Ministry for Primary Industries

schering-plough animal health limited - clostridium perfringens type d toxoid; levamisole phosphate; clostridium septicum toxoid; clostridium tetani toxoid; clostridium chauvoei toxoid/cells; clostridium novyi type b toxoid/cells - clostridium perfringens type d toxoid 0 vaccine; levamisole phosphate 100 g/litre; clostridium septicum toxoid 0 vaccine; clostridium tetani toxoid 0 vaccine; clostridium chauvoei toxoid/cells 0 vaccine; clostridium novyi type b toxoid/cells 0 vaccine - endoparasiticide

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - clostridium chauvoei - formol culture; leptospira interrogans serovar pomona; leptospira borgpetersenii serovar hardjo; clostridium novyi type b - toxoid; clostridium perfringens type d toxoid; clostridium septicum - toxoid; clostridium tetani - toxoid - misc. vaccines or anti sera - clostridium chauvoei - formol culture vaccine-microbial active 0.0 p; leptospira interrogans serovar pomona vaccine-microbial active 0.0 p; leptospira borgpetersenii serovar hardjo vaccine-microbial active 0.0 p; clostridium novyi type b - toxoid vaccine-toxoid active 0.0 p; clostridium perfringens type d toxoid vaccine-toxoid active 0.0 p; clostridium septicum - toxoid vaccine-toxoid active 0.0 p; clostridium tetani - toxoid vaccine-toxoid active 0.0 p - immunotherapy - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - black disease | blackleg | enterotoxaemia (pulpy kidney) | leptospirosis | malignant oedema | tetanus | clostridium perfringens type d | l. hardjo | l. interrogans | l. pomona | l. tarassovi | tetanus vaccination

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - clostridium chauvoei - formol culture; clostridium novyi type b - toxoid; clostridium perfringens type d toxoid; clostridium septicum - toxoid; clostridium tetani - toxoid; corynebacterium pseudotuberculosis (ovis) - toxoid; thiomersal - misc. vaccines or anti sera - clostridium chauvoei - formol culture vaccine-microbial active 0.0 u; clostridium novyi type b - toxoid vaccine-toxoid active 0.0 u; clostridium perfringens type d toxoid vaccine-toxoid active 0.0 u; clostridium septicum - toxoid vaccine-toxoid active 0.0 u; clostridium tetani - toxoid vaccine-toxoid active 0.0 u; corynebacterium pseudotuberculosis (ovis) - toxoid vaccine-toxoid active 0.0 u; thiomersal mercury other 0.1 mg/ml - immunotherapy - goat | goat kid | lamb | sheep | sheep ram (male) | billy | buck | capra hircus | doe | ewe | hogget | kid | lamb | ovine | ram - black disease | blackleg | caseous lymphadenitis (cheesy gland) | enterotoxaemia (pulpy kidney) | malignant oedema | swelled head | tetanus | clostridium perfringens type d | tetanus vaccination